This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Natera, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Phil Gauthier: Inventor in Transplant Rejection Analysis
Introduction
Phil Gauthier is an inventor based in Englewood, Colorado, whose patent work addresses methods for assessing transplant rejection. He is associated with Natera, Inc., a company involved in genetic testing and diagnostics.
Latest Patents
Gauthier is named on 1 patent: “Methods for Determination of Transplant Rejection.” The patent describes analyzing biological samples from transplant recipients by measuring the amount of torque teno virus (TTV) and donor-derived cell-free DNA in blood, plasma, serum, or urine. The measurements can help determine whether donor-derived cell-free DNA exceeds a threshold associated with rejection and whether TTV levels indicate a change in the recipient’s immune response.
Career Highlights
The patent reflects work on combining molecular measurements to support the assessment of transplant recipients. It describes using donor-derived cell-free DNA and TTV levels together to evaluate indicators associated with transplant rejection and immune response.
Collaborations
Gauthier’s listed coworkers include Paul Van Hummelen and Jessica Tang. The patent’s focus on sample preparation and analysis illustrates the collaborative, multidisciplinary nature of diagnostic innovation.
Conclusion
Phil Gauthier’s patent contribution centers on methods that combine viral and donor-derived DNA measurements to help assess transplant rejection and immune response.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile